Nonrefractive visual impairment in the United States has been found to have increased significantly in recent years, possibly related to an increase in prevalence of diabetes.
Viridian announces positive topline data from phase 3 THRIVE trial evaluating veligrotug in patients with active TED
Latest advances in X-linked retinitis pigmentosa: Optimizing diagnosis and developments in gene therapy
Biosimilars for retinal diseases: The long and winding road into clinical practice
Advancing the optimal diagnosis & treatment of thyroid eye disease
Prevent Blindness unveils Children’s Vision Health Map, corresponding report
Sonoma Pharmaceuticals, EMC Pharma roll out collaboration to co-market expanded eye care product line